Trial is designed to assess the Clotild sensor's capability to detect various characteristics of blood vessel blockages in peripheral artery disease patients.
Unique PlaqueTec Liquid Biopsy System will be used to collect blood samples containing biomolecules localizing at or being released by coronary plaque.
Owlstone Medical's Phase 2 clinical trial will assess the test's diagnostic performance and enable its optimization through testing protocol refinement.